Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
about
Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?Blood-Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit.HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive DysfunctionBioenergetic Mechanisms of Seizure Control
P2860
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@en
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@nl
type
label
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@en
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@nl
prefLabel
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@en
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis
@en
P2093
Alon Friedman
Arik Eisenkraft
Dan Z Milikovsky
Daniela Kaufer
Dror Rosenbach
Evyatar Swissa
Guy Bar-Klein
Hotjensa Dalipaj
Iris Noyman
Lyn Kamintsky
P2860
P304
P356
10.1093/BRAIN/AWX073
P407
P577
2017-06-01T00:00:00Z